The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor

被引:35
|
作者
Bien, Jeffrey [1 ]
Davulcu, Akin [1 ]
DelMonte, Albert J. [1 ]
Fraunhoffer, Kenneth J. [1 ]
Gao, Zhinong [1 ]
Hang, Chao [1 ]
Hsiao, Yi [1 ]
Hu, Wenhao [1 ]
Katipally, Kishta [1 ]
Littke, Adam [1 ]
Pedro, Aghogho [1 ]
Qiu, Yuping [1 ]
Sandoval, Maria [1 ]
Schild, Richard [1 ]
Soltani, Michelle [1 ]
Tedesco, Anthony [1 ]
Vanyo, Dale [1 ]
Vemishetti, Purushotham [1 ]
Waltermire, Robert E. [1 ]
机构
[1] Bristol Myers Squibb Co, Chem & Synthet Dev, One Squibb Dr,POB 191, New Brunswick, NJ 08903 USA
关键词
asymmetric; cyclopropanation; direct arylation; palladium; rhodium; catalysis; HEPATITIS-C VIRUS; REDUCTIVE ALKYLATION; INDOLES; DISCOVERY; RECEPTOR;
D O I
10.1021/acs.oprd.8b00214
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The process development and kilogram-scale synthesis of beclabuvir (BMS-791325, 1) is described. The convergent synthesis features the use of asymmetric catalysis to generate a chiral cyclopropane fragment and coupling with an indole fragment via an alkylation. Subsequent palladium-catalyzed intramolecular direct arylation efficiently builds the central seven-membered ring. The target was prepared in 12 linear steps with five isolations in an overall yield of 8%.
引用
收藏
页码:1393 / 1408
页数:16
相关论文
共 50 条
  • [21] Hepatitis C therapy with HCV NS5B polymerase inhibitors
    Soriano, Vincent
    Vispo, Eugenia
    de Mendoza, Carmen
    Labarga, Pablo
    Vicente Fernandez-Montero, Jose
    Poveda, Eva
    Trevino, Ana
    Barreiro, Pablo
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1161 - 1170
  • [22] CVVS-732: A Conformational Modulator of NS5B Polymerase Acting a Potent HCV Inhibitor
    Guedat, Philippe
    Valarche, Isabelle
    Lahmar, Mehdi
    Berecibar, Amaya
    Batard, Luc
    Bertrand, Angelina
    Martin, Aurelie
    Piessens, Annick
    Fernagut, Celine
    Freslon-Evain, Caroline
    Besnard, Lucie
    Ventura, Michel
    Durand, Tony
    Feray, Cyrille
    Mehtali, Majid
    GASTROENTEROLOGY, 2012, 142 (05) : S963 - S963
  • [23] Synthesis of New 4, 5-Dihydrofuranoindoles and Their Evaluation as HCV NS5B Polymerase Inhibitors
    Velazquez, Francisco
    Venkatraman, Srikanth
    Lesburg, Charles A.
    Duca, Jose
    Rosenblum, Stuart B.
    Kozlowski, Joseph A.
    Njoroge, F. George
    ORGANIC LETTERS, 2012, 14 (02) : 556 - 559
  • [24] Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors
    Zhou, Longhu
    Amblard, Franck
    Zhang, Hongwang
    McBrayer, Tamara R.
    Detorio, Mervi A.
    Whitaker, Tony
    Coats, Steven J.
    Schinazi, Raymond F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3385 - 3388
  • [25] Synthesis and SAR studies on rhodanine analogs as allosteric inhibitors of HCV NS5B polymerase
    Patel, Bhargav
    Kaushik-Basu, Neerja
    Khadtare, Nikhil
    Kr, Gurukumar
    Basu, Amartya
    Arora, Payal
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [26] IDX21437, a novel nucleotide analogue prodrug HCV NS5B polymerase inhibitor
    Sullivan-Bolyai, J.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 31 - 32
  • [27] Discovery of ABT-072, a potent inhibitor of HCV NS5B polymerase in clinical trials
    Randolph, John T.
    Krueger, Allen C.
    Donner, Pamela L.
    Motter, Christopher E.
    Pratt, John K.
    Liu, Dachun
    Rockway, Todd W.
    Wagner, Rolf
    Hernandez, Lisa E.
    Beno, David W. A.
    Lim, Hock B.
    Beyer, Jill M.
    Mondal, Rubina
    Mistry, Neeta
    Colletti, Lynn
    Liu, Yaya
    Koev, Gennadiy
    Kati, Warren M.
    Longenecker, Kenton L.
    Stewart, Kent D.
    Molla, Akhteruzzaman
    Maring, Clarence J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [28] In vitro and in vivo ADME of a new hepatitis C virus (HCV) NS5B polymerase inhibitor
    Rioux, N
    Dong, KC
    Richard, A
    Roberge, G
    Bédard, J
    Chan, L
    Thumkunta, RJ
    Proulx, M
    Hamelin, BA
    DRUG METABOLISM REVIEWS, 2003, 35 : 39 - 39
  • [29] Robust suppression of viral replication in HCV infected chimpanzees by a nucleoside inhibitor of the NS5B polymerase
    Olsen, D. B.
    Carroll, S. S.
    Davies, M-El
    Handt, L.
    Koeplinger, K.
    Zhang, R.
    Ludmerer, S.
    MacCoss, M.
    Hazuda, D. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S7 - S7
  • [30] Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition
    Bhatt, Aaditya
    Gurukumar, K. R.
    Basu, Amartya
    Patel, Maulik R.
    Kaushik-Basu, Neerja
    Talele, Tanaji T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (10) : 5138 - 5145